Column Group Opportunity III GP, LP
Insider CIK 1932874 · NGM 10% owner · SRZN 10% owner · TNYA 10% owner · EIKN 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SRZN Surrozen, Inc./DE | X Exercise deriv | 2026-10-20 | 2026-10-22 | 258,620 | — | — | 431,034 | SEC↗ |
| SRZN Surrozen, Inc./DE | X Exercise deriv | 2026-10-20 | 2026-10-22 | 274,327 | — | — | 457,211 | SEC↗ |
| SRZN Surrozen, Inc./DE | X Exercise deriv | 2026-10-20 | 2026-10-22 | 242,915 | — | — | 404,858 | SEC↗ |
| SRZN Surrozen, Inc./DE | X Exercise deriv | 2026-10-20 | 2026-10-22 | 775,861 | — | — | 0 | SEC↗ |
| SRZN Surrozen, Inc./DE | X Exercise deriv | 2026-10-20 | 2026-10-22 | 822,980 | — | — | 0 | SEC↗ |
| SRZN Surrozen, Inc./DE | X Exercise deriv | 2026-10-20 | 2026-10-22 | 728,745 | — | — | 0 | SEC↗ |
| SRZN Surrozen, Inc./DE | X Exercise | 2026-10-20 | 2026-10-22 | 517,241 | $11.60 | $6.00M | 862,068 | SEC↗ |
| SRZN Surrozen, Inc./DE | X Exercise | 2026-10-20 | 2026-10-22 | 548,653 | $11.60 | $6.36M | 1,565,311 | SEC↗ |
| SRZN Surrozen, Inc./DE | X Exercise | 2026-10-20 | 2026-10-22 | 485,830 | $11.60 | $5.64M | 1,386,122 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | P Buy | 2026-09-03 | 2026-09-08 | 89,200 | $11.56 | $1.03M | 89,200 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | P Buy | 2026-09-03 | 2026-09-08 | 89,200 | $11.56 | $1.03M | 89,200 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2026-02-25 | 2026-02-26 | 1,862,545 | $0.56 | $1.04M | 0 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2026-02-25 | 2026-02-26 | 1,649,281 | $0.56 | $923.6K | 0 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2026-02-24 | 2026-02-26 | 309,228 | $0.62 | $191.7K | 1,649,281 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2026-02-24 | 2026-02-26 | 349,212 | $0.62 | $216.5K | 1,862,545 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2026-02-23 | 2026-02-24 | 143,709 | $0.60 | $86.2K | 1,958,509 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2026-02-23 | 2026-02-24 | 162,291 | $0.60 | $97.4K | 2,211,757 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2026-02-20 | 2026-02-24 | 245,965 | $0.61 | $150.0K | 2,102,218 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2026-02-20 | 2026-02-24 | 277,769 | $0.61 | $169.4K | 2,374,048 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2026-02-11 | 2026-02-12 | 1,905,115 | $0.68 | $1.30M | 2,348,183 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2026-02-11 | 2026-02-12 | 2,151,458 | $0.68 | $1.46M | 2,651,817 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2026-02-10 | 2026-02-12 | 182,295 | $0.82 | $149.5K | 4,803,275 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2026-02-10 | 2026-02-12 | 161,422 | $0.82 | $132.4K | 4,253,298 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-09 | 10,467,526 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-09 | 330,000 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-09 | 827,278 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-09 | 357,216 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-09 | 9,670,000 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-09 | 28,229 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-09 | 5,133,076 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-06 | 2026-02-09 | 47,898 | — | $0 | 95,499 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-06 | 2026-02-09 | 44,249 | — | $0 | 47,601 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-06 | 2026-02-09 | 110,928 | — | $0 | 2,874,816 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-06 | 2026-02-09 | 1,403,568 | — | $0 | 2,763,888 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-06 | 2026-02-09 | 1,296,629 | — | $0 | 1,360,320 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | P Buy | 2026-02-06 | 2026-02-09 | 1,437,323 | $18.00 | $25.87M | 4,312,139 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | P Buy | 2026-02-06 | 2026-02-09 | 49,556 | $18.00 | $892.0K | 148,840 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-06 | 2026-02-09 | 3,785 | — | $0 | 99,284 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-06 | 2026-02-09 | 688,283 | — | $0 | 688,283 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | P Buy | 2026-02-06 | 2026-02-09 | 630,881 | $18.00 | $11.36M | 1,319,164 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy | 2026-01-20 | 2026-01-20 | 8,484 | $19.60 | $166.3K | 900,292 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy | 2026-01-20 | 2026-01-20 | 9,568 | $19.60 | $187.5K | 1,016,658 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy | 2026-01-16 | 2026-01-20 | 1,204 | $20.00 | $24.1K | 891,808 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy | 2026-01-16 | 2026-01-20 | 1,358 | $20.00 | $27.2K | 1,007,090 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy | 2026-01-15 | 2026-01-20 | 6,303 | $19.89 | $125.4K | 1,005,732 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy | 2026-01-15 | 2026-01-20 | 5,590 | $19.89 | $111.2K | 890,604 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy | 2026-01-14 | 2026-01-15 | 2,596 | $19.99 | $51.9K | 885,014 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy | 2026-01-14 | 2026-01-15 | 2,927 | $19.99 | $58.5K | 999,429 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy | 2026-01-13 | 2026-01-15 | 6,609 | $19.80 | $130.9K | 996,502 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy | 2026-01-13 | 2026-01-15 | 5,861 | $19.80 | $116.0K | 882,418 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy | 2026-01-06 | 2026-01-08 | 8,003 | $19.89 | $159.2K | 989,893 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy | 2026-01-06 | 2026-01-08 | 7,097 | $19.89 | $141.2K | 876,557 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy | 2025-12-05 | 2025-12-08 | 16,381 | $19.54 | $320.1K | 981,890 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy | 2025-12-05 | 2025-12-08 | 14,503 | $19.54 | $283.4K | 869,460 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy | 2025-12-04 | 2025-12-08 | 2,791 | $17.35 | $48.4K | 965,509 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy | 2025-12-04 | 2025-12-08 | 2,475 | $17.35 | $42.9K | 854,957 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy | 2025-11-13 | 2025-11-17 | 148,150 | $12.65 | $1.87M | 852,482 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy | 2025-11-13 | 2025-11-17 | 167,307 | $12.65 | $2.12M | 962,718 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy deriv | 2025-03-26 | 2025-03-28 | 161,943 | — | $0 | 161,943 | SEC↗ |
| SRZN Surrozen, Inc./DE | H Expire deriv | 2025-03-26 | 2025-03-28 | 397,773 | — | $0 | 0 | SEC↗ |
| SRZN Surrozen, Inc./DE | H Expire deriv | 2025-03-26 | 2025-03-28 | 352,225 | — | $0 | 0 | SEC↗ |
| SRZN Surrozen, Inc./DE | H Expire deriv | 2025-03-26 | 2025-03-28 | 397,773 | — | $0 | 0 | SEC↗ |
| SRZN Surrozen, Inc./DE | H Expire deriv | 2025-03-26 | 2025-03-28 | 352,225 | — | $0 | 0 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy deriv | 2025-03-26 | 2025-03-28 | 111,656 | — | $0 | 111,656 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy deriv | 2025-03-26 | 2025-03-28 | 517,241 | — | $0 | 517,241 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy deriv | 2025-03-26 | 2025-03-28 | 98,870 | — | $0 | 98,870 | SEC↗ |
| SRZN Surrozen, Inc./DE | H Expire deriv | 2025-03-26 | 2025-03-28 | 98,870 | — | $0 | 0 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy deriv | 2025-03-26 | 2025-03-28 | 102,651 | — | $0 | 102,651 | SEC↗ |
| SRZN Surrozen, Inc./DE | H Expire deriv | 2025-03-26 | 2025-03-28 | 102,651 | — | $0 | 0 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy deriv | 2025-03-26 | 2025-03-28 | 90,897 | — | $0 | 90,897 | SEC↗ |
| SRZN Surrozen, Inc./DE | H Expire deriv | 2025-03-26 | 2025-03-28 | 90,897 | — | $0 | 0 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy deriv | 2025-03-26 | 2025-03-28 | 182,884 | — | $0 | 182,884 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy deriv | 2025-03-26 | 2025-03-28 | 172,414 | — | $0 | 172,414 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy deriv | 2025-03-26 | 2025-03-28 | 485,830 | — | $0 | 485,830 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy deriv | 2025-03-26 | 2025-03-28 | 548,653 | — | $0 | 548,653 | SEC↗ |
| SRZN Surrozen, Inc./DE | H Expire deriv | 2025-03-26 | 2025-03-28 | 111,656 | — | $0 | 0 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy | 2025-03-26 | 2025-03-28 | 323,886 | $11.60 | $3.76M | 704,332 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy | 2025-03-26 | 2025-03-28 | 365,769 | $11.60 | $4.24M | 795,411 | SEC↗ |
| SRZN Surrozen, Inc./DE | P Buy | 2025-03-26 | 2025-03-28 | 344,827 | $11.60 | $4.00M | 344,827 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | P Buy deriv | 2025-03-05 | 2025-03-07 | 35,714,284 | — | $0 | 35,714,284 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | P Buy deriv | 2025-03-05 | 2025-03-07 | 17,857,142 | — | $0 | 17,857,142 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | P Buy | 2025-03-05 | 2025-03-07 | 35,714,284 | $0.70 | $25.00M | 49,313,559 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer | 2024-04-05 | 2024-04-08 | 2,650,177 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer | 2024-04-05 | 2024-04-08 | 949,862 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer | 2024-04-05 | 2024-04-08 | 90,442 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer | 2024-04-05 | 2024-04-08 | 11,103,333 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer | 2024-04-05 | 2024-04-08 | 858,035 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer | 2024-04-05 | 2024-04-08 | 968,990 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer | 2024-04-05 | 2024-04-08 | 2,265,758 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer | 2024-04-05 | 2024-04-08 | 1,298,908 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer | 2024-04-05 | 2024-04-08 | 1,298,908 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer | 2024-04-05 | 2024-04-08 | 100,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer | 2024-04-05 | 2024-04-08 | 100,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer | 2024-04-05 | 2024-04-08 | 15,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer | 2024-04-05 | 2024-04-08 | 44,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | J Other | 2024-04-05 | 2024-04-08 | 1,000 | — | $0 | 1,000 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | P Buy | 2024-02-12 | 2024-02-14 | 2,222,222 | $4.50 | $10.00M | 13,599,275 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | P Buy | 2023-11-16 | 2023-11-17 | 5,840 | $0.62 | $3.6K | 949,862 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | P Buy | 2023-11-15 | 2023-11-17 | 16,791 | $0.71 | $11.9K | 944,022 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | P Buy | 2023-03-10 | 2023-03-14 | 6,779 | $2.60 | $17.6K | 11,377,053 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | P Buy | 2023-02-08 | 2023-02-10 | 1,500,000 | $2.60 | $3.90M | 11,370,274 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | P Buy | 2023-01-31 | 2023-02-01 | 176,730 | $5.00 | $883.6K | 927,231 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | P Buy | 2023-01-30 | 2023-02-01 | 7,542 | $5.00 | $37.7K | 750,501 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | P Buy | 2023-01-23 | 2023-01-25 | 9,900 | $5.00 | $49.5K | 742,959 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | P Buy | 2023-01-20 | 2023-01-23 | 500 | $5.00 | $2.5K | 733,059 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | P Buy | 2023-01-19 | 2023-01-23 | 37,639 | $5.00 | $188.2K | 732,559 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | P Buy | 2023-01-19 | 2023-01-23 | 69,739 | $2.50 | $174.3K | 9,870,274 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | P Buy | 2023-01-18 | 2023-01-19 | 135,688 | $2.52 | $341.9K | 9,800,535 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | P Buy | 2023-01-17 | 2023-01-19 | 49,463 | $2.49 | $123.2K | 9,664,847 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | P Buy | 2023-01-12 | 2023-01-17 | 5,378 | $4.95 | $26.6K | 694,920 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | P Buy | 2023-01-11 | 2023-01-12 | 209,000 | $4.76 | $994.8K | 689,542 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | P Buy | 2023-01-10 | 2023-01-12 | 100,070 | $4.84 | $484.3K | 480,542 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | P Buy | 2022-12-12 | 2022-12-14 | 300 | $4.98 | $1.5K | 380,472 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | P Buy | 2022-11-22 | 2022-11-23 | 4,330 | $5.00 | $21.6K | 380,172 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | P Buy | 2022-11-21 | 2022-11-23 | 9,615,384 | $2.60 | $25.00M | 9,615,384 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | P Buy | 2022-11-21 | 2022-11-23 | 35,997 | $5.00 | $180.0K | 375,842 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | P Buy | 2022-11-04 | 2022-11-07 | 35,058 | $4.72 | $165.5K | 339,845 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | P Buy | 2022-11-03 | 2022-11-07 | 104,090 | $4.99 | $519.4K | 304,787 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | P Buy | 2022-10-27 | 2022-10-31 | 76,877 | $4.86 | $373.6K | 200,697 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | P Buy | 2022-10-26 | 2022-10-27 | 72,774 | $4.85 | $353.0K | 123,820 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | P Buy | 2022-10-25 | 2022-10-27 | 51,046 | $4.75 | $242.5K | 51,046 | SEC↗ |